drugset / Trial / NCT00000503
Randomized Clinical Trial of Non-Surgical Reperfusion of the Coronary Arteries
RandomizedDouble-blindTreatment
Summary
To assess the effect of non-surgical reperfusion on infarct size in patients with acute myocardial infarction.
Timeline
- Start
- 1982-08
- Primary completion
- —
- Completion
- 1987-10
Publications
- Background Rentrop KP, Feit F, Sherman W, Stecy P, Hosat S, Cohen M, Rey M, Ambrose J, Nachamie M, Schwartz W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol. 1989 Jul;14(1):58-64. doi: 10.1016/0735-1097(89)90054-5.
- Zhan S, Wang J, Zhu M, Liu Y, Han F, Sun L, Wang Q, Huang Z. The Inhibitory Effects of NCT503 and Exogenous Serine on High-Selenium Induced Insulin Resistance in Mice. Nutrients. 2025 Jan 16;17(2):311. doi: 10.3390/nu17020311.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitroglycerin | Unknown | — | Other |
| Subject | Streptokinase | Protein / enzyme biologic | — | Other |